2017 Bio-Forum in San Francisco
Gallery: Bio-Forum San Fran 2017
Frontage Laboratories, Inc. hosted an invitation-only scientific symposium on the evening of March 23, 2017 in San Francisco, CA. This exclusive event is part of our Bio-Forum Series. The evening included four presentations by key industry and academic leaders, a networking reception and dinner. Following the presentations, there was a panel session where the audience had the opportunity to ask the speakers follow-up questions about their presentations, industry challenges and trends.
Frontage will host a similar event in Princeton in the summertime. If you have any interest in attending one of our future Bio-Forum events, please reach out to us at firstname.lastname@example.org.
Below is a brief overview of the exciting topics that were discussed:
Reed Selby (Sr. Business Development Executive, Metabolon), delivered opening remarks. His talk was titled, "Leveraging Metabolomics to Deliver the Target Product Profile".
Dr. Valerie Quarmby (Staff Scientist and Director of the Department of Bioanalytical Sciences at Genentech) She gave a talk titled, “Immunogenicity Assessment: Analytical Challenges & Solutions".
Dr. David Hung, Founder (President and CEO of Medivation Inc.) He was our keynote speaker. His talk was titled, "The Other Story Behind Medivation".
Dr. Daniel Sikkema (VP Biologics, Frontage Laboratories, Inc.) He delivered closing remarks, bringing together Pioneers of Drug Discovery with Applied Drug Development Leaders to inspire future collaboration.